Alnara Pharmaceuticals, Inc. is founded in 2008. The company operates in the Manufacturing, Pharmaceuticals sector.
Alnara Pharmaceuticals, Inc. specializes in Protein therapy development, Oral drug delivery systems, Metabolic disease treatments, and offers services including Novel protein therapeutics, Orally deliverable protein therapies.
Total Rounds
US$ 35M
Last Round
US$ 35M
Rounds
1
Investors
MPM Capital